First four failures of cefathiamidine to treat urogenital gonorrhoea in Guangzhou, China, 2014-15

Sex Health. 2017 Jun;14(3):289-292. doi: 10.1071/SH16087.

Abstract

Neisseria gonorrhoeae has a remarkable ability to develop resistance to all available therapeutic antimicrobials. This report describes the first four cases of verified failure to treat gonorrhoea using 1000mg cefathiamidine intramuscularly in Guangzhou, China; for each case, the patient was clinically cured after treatment with 500mg ceftriaxone intramuscularly. Enhanced monitoring of clinical treatment failures, finding new effective treatments and updating treatment guidelines are all of utmost importance to curb the spread of drug-resistant gonorrhoea.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Cephalosporins / therapeutic use*
  • China
  • Gonorrhea / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Real-Time Polymerase Chain Reaction
  • Treatment Failure

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • cefathiamidine